Assessment by independent medical practitioner of research candidate’s best interests
110ZU Assessment by independent medical practitioner of research candidate’s best interests
An independent medical practitioner must take into account the following in making a determination under section 110ZR(3)(a) or 110ZS(1)(h) —
the wishes of the research candidate (to the extent they can be ascertained) as the paramount consideration;
the likely effects of the research candidate’s participation, including —
the existence, likelihood and severity of any potential risks to the candidate; and
whether those risks are justified by any likely benefits of the research to the candidate or to the broader community;
any consequences for the research candidate if they are not involved in the research;
any alternative treatments available to the research candidate;
any other prescribed matters.
The fact that medical research may involve the giving of placebos does not prevent a research decision‑maker or an independent medical practitioner from being satisfied that it is in the best interests of a research candidate or is not adverse to the interests of the candidate that they participate in the research.
The independent medical practitioner must inform a research decision‑maker or researcher of the practitioner’s determination, and the reasons for the determination —
if practicable before the medical research commences — in writing; or
if paragraph (a) does not apply —
orally before the medical research commences; and
in writing after the research candidate commences participation in the medical research.
[Section 110ZU inserted: No. 14 of 2020 s. 12.]
This provision refers to the regulations (prescribed matters
). Made under this Act:
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.